期刊文献+

化学前沿(2014年6月发布)

The Cutting Edge of Chemistry(Issued June 2014)
原文传递
导出
摘要 "化学前沿"通过化学家的视角,揭示了生物医药研究领域内新的理念和成就。报告中的见解和信息来自汤森路透Integrity数据库。该数据库整合了生物学、化学和药理学信息。2014年6月发布的报告包括有机合成路线展示、研究中的分子骨架、新化合物的作用机制、新研发管线等几个部分,分章别类地阐述了筛选疗效和安全性更好的药物的基本方面,并介绍了帕金森病治疗药物的研究现状。 The Cutting Edge of Chemistry discloses new ideas and achievements in the biomedical research field with the chemist's perspective in mind. Insights and information within this report are drawn from Thomson Reuters Integrity, the drug discovery database that combines biology, chemistry and pharmacology information. The report issued June 2014 has been organized into sections,including organic synthesis scheme showcase,scaffolds on the mode,new molecular mechanisms of action and the starling line ,which delineate essential aspects of the search for better and safer drugs.And the research status of orphan drugs has also been introduced.
机构地区 汤森路透
出处 《药学进展》 CAS 2015年第1期63-72,共10页 Progress in Pharmaceutical Sciences
关键词 生物医药研究 有机合成 分子骨架 帕金森病 biomedical research organic synthesis scaffold Parkinson's disease
  • 相关文献

参考文献35

  • 1Reitz C.Brayne C,Mayeux R. Epidemiology of Alzheimer disease[J].Nat Rev Neurol, 2012, 7(3): 137.
  • 2Sigurdsson E M. Tau immunotherapy and imaging[J]. Neurodegener0/;v,2014, 13(2/3): 103.
  • 3Graham T J.Lambert R F.PIoessI K,et al. Enantioselective radiosynthesisof positron emission tomography (PET) tracers containing [|!>F]fiuorohydrins[J].y^ffl Chem Soc.2014, 136(14): 5291.
  • 4Rotstein B H,Hooker J M,Woo J,et al. Synthesis of [uC]bexaroteneby Cu-mcdiatcd [nC]carbon dioxide fixation and preliminary PETimaging[J]. ACS Med Chem Lett、2014,5(6):668-672.
  • 5Shudo K,Fukasawa H,Nakagomi M,et al. Towards retinoid therapy forAlzheimer's dhcasc[i].Cnrr Alzheimer ^,2009, 6(3): 302.
  • 6LaClair K D,Manaye K. F, Lee D L,et al. Treatment with bexarotene, acompound that increases apolipoprotein-E, provides no cognitive benefitin mutant A PP/PS 1 mice[J]. Mo/ Neurodegenei\2013, 8:18.
  • 7Shipe W D, Ahcywickrema P D,Barrow J C, et al. Discovery andoptimization of a series of pyrimidine PDEI0 inhibitors throughfragment screening, structure-based design, and parallel synthesis: 247thACS Natl Meet, Dallas, March 16-20, 2014[C].[S.I.].[s.n.],c2014:AbstMEDI 20.
  • 8Punj S,Kopparapu P,Jang H S,el al. Benzimidazoisoquinolines: a newclass of rapidly metabolized aryl hydrocarbon receptor (AhR) ligandsthat induce AhR-dependcnt Tregs and prevent murine graftversus-hostdisease[J]. PLoS 0^,2014, 9(2): c88726.
  • 9Cinelli M A,Li H,Chreifi G,et al. Simplified 2-aininoquinoiine-based scaffold for potent and selective neuronal nitric oxide synthaseinhibition[J]. J Med Chem,2014, 57(4): 1513.
  • 10Farghaiy T A’Gomha S M’Abdalla M M.Synthesis of a new series ofangiotensin II receptor antagonists and antibacterial agents[J]. ArchPharmacal Res,2i) 14, 37(3): 306.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部